Biologics will participate in late-stage trial of Neupogen

02/11/2010 | American City Business Journals

The National Marrow Donor Program chose North Carolina's Biologics to oversee inventory and distribution of Neupogen, a drug that boosts white blood cells, during a Phase III trial involving blood stem cell transplant patients with unrelated donors. The trial has been going on since 1997 and is expected to enroll 15,000 participants by 2012.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX